This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_CERVIX_ADENO_EXALLC for full statistics.
Adenocarcinomas of cervix
C3_CERVIX_ADENO
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
150 |
4. Check minimum number of eventsNone |
150 |
5. Include endpointsNone |
150 |
6. Filter based on genotype QC (FinnGen only) |
150 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Adenocarcinomas of cervix
based on the number of shared cases.
Similar with more cases:
- Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of cervix uteri
- Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 150 | 150 | - |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | - |
| Median age at first event (years) | 42.97 | 42.97 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 154
- Matched controls
- 1540
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C53.02
ICD-10 Finland
Adenocarcinoma of the endocervix
+∞
135.0
109
*
8140/3-C53.9
ICD-O-3
Adenocarcinoma, NOS, of cervix uteri
+∞
112.8
94
*
8140/3-C53.0
ICD-O-3
Adenocarcinoma, NOS, of endocervix
+∞
54.5
49
*
LDC03
NOMESCO Finland
Conisation of cervix uteri using diathermy or laser
24.0
49.1
74
57
128
Kela drug reimbursment
Cancers of female genital organs
72.3
47.7
53
11
ULA02
NOMESCO Finland
Kolposcopy
15.0
47.4
96
153
C53.12
ICD-10 Finland
Adenocarcinoma of the exocervix
+∞
40.4
37
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
129.5
37.7
39
*
LCD31
NOMESCO Finland
Radical laparoscopic hysterectomy
241.3
37.6
37
*
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
10.9
37.5
88
167
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
9.3
31.8
80
160
ZXC96
NOMESCO Finland
Robot assisted procedure
96.1
29.0
31
*
LEB00
NOMESCO Finland
Biopsy of vagina
30.0
27.7
37
16
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
88.5
26.8
29
*
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
9.3
25.6
59
96
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
46.3
22.6
27
7
LCD30
NOMESCO Finland
Radical hysterectomy
254.7
22.2
22
*
WF002
NOMESCO Finland
Radical radiotherapy
26.9
19.9
27
12
D06.0
ICD-10 Finland
Carcinoma in situ: Endocervix
53.6
19.8
23
5
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
22.5
19.5
28
15
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
76.0
18.2
20
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
76.0
18.2
20
*
C53.00
ICD-10 Finland
Malignant tumor of endocervix without histology
+∞
18.1
17
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
13.2
18.0
32
30
LDA10
NOMESCO Finland
Curettage of cervix uteri
8.9
18.0
40
58
B01AB10
ATC
tinzaparin; parenteral
9.5
17.8
38
51
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
57.0
17.5
20
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
26.7
17.0
23
10
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
14.6
16.7
28
23
121
Kela drug reimbursment
Severe hypofunction of sexual glands
17.1
16.6
26
18
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
9.6
16.2
34
44
C53.0
ICD-10 Finland
Malignant neoplasm: Endocervix
+∞
15.9
15
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
10.4
15.1
30
35
C53.01
ICD-10 Finland
Squamous cell carcinoma of the endocervix
165.0
14.7
15
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
82.3
13.8
15
*
A03FA01
ATC
metoclopramide; systemic, rectal
4.2
13.6
64
225
H02AB02
ATC
dexamethasone; systemic
5.8
12.9
39
85
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
12.7
12
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.6
12.6
82
371
B01AB05
ATC
enoxaparin; parenteral
3.7
12.5
73
304
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
51.0
12.1
14
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
51.0
12.1
14
*
C53.09
ICD-10 Finland
Malignant tumor of endocervix, unspecified histology
+∞
11.6
11
*
8140/3-C53.1
ICD-O-3
Adenocarcinoma, NOS, of exocervix
+∞
11.6
11
*
XX3DW
NOMESCO Finland
Time consuming IT work
5.3
11.3
36
83
LCA06
NOMESCO Finland
Biopsy of endometrium
4.3
11.1
46
140
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
4.1
10.9
48
154
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
17.7
10.6
16
10
ZX040
NOMESCO Finland
Intracavity HDR radiotherapy
58.8
9.8
11
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
19.1
9.6
14
8
1800A
ICD-9 Finland
Malignant neoplasm of cervix uteri, Endocervix
+∞
9.5
9
*
C53
ICD-10 Finland
Malignant neoplasm of cervix uteri
+∞
9.5
9
*
C53.92
ICD-10 Finland
Adenocarcinoma in an unspecified location in the cervix
+∞
9.5
9
*
JN4BD
NOMESCO Finland
Extensive body CT
4.5
9.2
34
91
UKC02
NOMESCO Finland
Cystoscopy
4.7
8.9
31
78
A04AA55
ATC
palonosetron, combinations; systemic
7.2
8.9
21
33
LBE10
NOMESCO Finland
Bilateral salpingectomy
+∞
8.4
8
*
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
47.4
7.8
9
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
19.6
7.7
11
6
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
10.9
7.7
14
14
A04AA01
ATC
ondansetron; systemic, rectal
4.7
7.7
26
64
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.6
7.6
80
449
8310
FHL
Radical hysterectomy (includes lymph node removal)
84.0
7.5
8
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
8.0
7.4
16
22
C53.90
ICD-10 Finland
Malignant tumor in unspecified localization in cervix uteri without histology
+∞
7.3
7
*
C53.99
ICD-10 Finland
Malignant tumor in unspecified localization in cervix, unspecified histology
+∞
7.3
7
*
C53.11
ICD-10 Finland
Squamous cell carcinoma and exocervix
31.6
7.2
9
*
P01AB01
ATC
metronidazole; oral, rectal
2.5
7.1
85
507
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
8.9
7.0
14
17
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
23.7
6.8
9
*
8077/2-C53.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of cervix uteri
8.0
6.6
14
19
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
72.7
6.5
7
*
KBV00
NOMESCO Finland
Insertion of stent into ureter
72.7
6.5
7
*
WX402
NOMESCO Finland
General anaesthesia
3.0
6.5
39
154
A04AA02
ATC
granisetron; systemic, transdermal
5.1
6.4
19
41
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
19.0
6.3
9
5
C53.1
ICD-10 Finland
Malignant neoplasm: Exocervix
+∞
6.3
6
*
C53.9
ICD-10 Finland
Malignant neoplasm: Cervix uteri, unspecified
+∞
6.3
6
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
9.2
6.2
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
41
80
6.68
21.48
2.4
1.4
—
—
—
0
0
81
360
3.72
14.28
2.5
1.4
—
—
—
0
0
104
648
2.97
8.82
6.4
5.1
0.0
0.0
estimate
0.00
26
133
103
653
2.84
8.19
4.9
3.8
0.0
0.0
estimate
0.00
25
131
79
441
2.67
8.07
4.0
2.9
—
—
—
0
0
32
115
3.27
7.30
2.4
3.6
—
—
—
0
0
27
87
3.57
7.29
1.8
1.5
—
—
—
0
0
100
650
2.62
7.14
4.9
3.8
0.0
0.0
estimate
0.00
26
135
93
600
2.45
6.51
4.9
4.0
—
—
—
0
0
14
35
4.31
5.30
4.6
1.9
1.1
1.3
mg/l
0.99
14
30
104
745
2.29
5.19
13.1
9.2
3.9
4.1
e9/l
0.27
96
655
117
891
2.42
4.90
6.6
4.9
2638.3
250.2
e6/l
—
7
17
79
516
2.12
4.87
6.6
3.9
34.6
36.1
g/l
1.40
73
476
60
364
2.08
4.40
5.5
4.2
0.0
0.0
estimate
0.00
25
135
57
343
2.07
4.24
3.8
2.8
0.5
0.4
e6/l
0.26
45
249
36
200
2.05
3.23
3.1
2.6
0.9
1.1
e6/l
0.37
21
109
118
968
2.03
3.15
9.2
7.0
81.5
75.6
u/l
0.47
112
888
22
106
2.26
2.80
3.1
2.4
0.2
0.2
g/l
1.42
22
100
72
520
1.74
2.80
5.2
3.9
—
—
—
0
0
86
667
1.68
2.47
7.7
5.4
7.9
9.9
umol/l
2.85
81
626
16
71
2.40
2.44
1.9
1.4
—
—
—
0
0
88
693
1.65
2.33
3.5
4.1
6.2
6.5
mmol/l
0.95
80
633
43
284
1.72
2.22
2.2
2.1
—
—
—
0
0
71
536
1.62
2.19
4.5
5.1
1.2
1.2
mmol/l
0.42
62
482
20
105
2.04
2.07
3.8
6.3
0.7
1.3
mmol/l
0.35
12
85
30
184
1.79
1.98
3.3
2.8
2.7
4.8
e6/l
0.74
18
94
44
314
1.57
1.64
2.6
2.2
3.3
3.1
mg/l
0.16
38
275
12
58
2.16
1.54
3.1
7.9
0.7
0.7
%
0.03
12
58
12
58
2.16
1.54
3.1
7.9
1.2
1.3
%
0.11
12
58
23
141
1.75
1.53
9.6
6.0
—
—
—
0
0
138
1283
1.95
1.40
19.3
12.8
30.2
19.6
mg/l
2.41
118
975
13
68
2.00
1.38
3.3
2.2
368.7
1951.7
u/l
—
7
28
113
1236
0.65
1.37
3.5
3.9
1.6
1.6
mmol/l
0.93
106
1140
114
1240
0.66
1.26
3.6
4.0
5.0
4.8
mmol/l
1.36
107
1152
73
604
1.41
1.25
5.7
5.7
1.2
1.2
mmol/l
1.22
59
502
10
50
2.07
1.19
1.3
1.7
—
—
—
0
0
24
161
1.58
1.16
1.9
1.8
29.6
29.7
s
0.06
24
156
7
33
2.17
1.07
1.4
1.4
—
—
—
0
0
104
1140
0.71
1.06
4.4
5.1
37.9
38.7
mmol/mol
0.43
97
1062
7
36
1.99
0.98
1.4
1.3
—
—
—
0
0
118
1262
0.70
0.97
3.9
4.4
2.9
2.8
mmol/l
0.50
110
1164
28
203
1.47
0.96
4.4
3.3
483.0
71.2
ng/l
0.65
22
137
7
128
0.52
0.93
1.3
1.7
—
—
—
0
0
6
28
2.19
0.92
1.0
1.1
—
—
—
0
0
6
28
2.19
0.92
1.0
1.1
—
—
—
0
0
18
120
1.57
0.90
1.8
1.7
—
—
—
0
0
140
1334
1.74
0.90
22.3
14.1
72.1
68.6
umol/l
0.90
140
1334
21
287
0.69
0.81
1.2
1.3
150.5
34.1
iu/ml
—
6
99
0
28
0.00
0.77
0.0
1.3
—
—
—
0
0
52
436
1.29
0.74
3.3
3.4
28.4
32.6
ng/l
0.11
28
261
39
314
1.33
0.74
1.4
1.5
21.6
22.8
nmol/l
0.20
32
264
22
291
0.71
0.71
1.1
1.3
46.7
10.7
u/ml
—
7
117
78
867
0.79
0.70
2.9
2.7
41.1
37.2
u/l
0.18
71
811
111
1181
0.77
0.67
3.1
3.6
1.3
1.2
mmol/l
0.98
103
1081
17
121
1.46
0.66
1.8
1.6
—
—
—
0
0
6
103
0.57
0.64
1.3
1.6
—
—
—
0
0
5
29
1.75
0.64
1.0
1.5
—
—
—
0
0
5
30
1.69
0.62
1.0
1.5
—
—
—
0
0
0
20
0.00
0.61
0.0
1.0
—
—
—
0
0
0
21
0.00
0.60
0.0
2.1
—
18.5
—
0
12
0
22
0.00
0.60
0.0
1.8
—
—
—
0
0
140
1352
1.53
0.58
13.0
9.7
22.2
22.8
u/l
0.24
135
1302
25
313
0.76
0.57
2.7
2.8
310.4
5373.5
umol/l
1.58
20
266
7
50
1.42
0.45
1.3
1.4
—
—
—
0
0
13
96
1.39
0.43
4.2
3.2
4.2
4.5
pmol/l
0.43
13
87
0
15
0.00
0.41
0.0
1.5
—
13.3
—
0
15
116
1209
0.82
0.40
4.1
4.2
5.6
5.7
mmol/l
0.85
109
1110
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
66
603
1.17
0.38
2.3
2.3
70.3
77.8
nmol/l
1.96
56
542
27
317
0.82
0.37
1.5
1.6
—
—
—
0
0
38
332
1.19
0.37
1.4
1.3
0.6
1.1
u/ml
0.84
18
86
56
508
1.16
0.35
2.0
1.9
96.8
100.4
pmol/l
0.24
29
250
6
44
1.38
0.35
1.0
1.1
—
—
—
0
0
7
57
1.24
0.29
1.1
1.2
—
—
—
0
0
29
330
0.85
0.29
1.5
1.6
1.3
1.3
mmol/l
0.03
24
273
8
67
1.20
0.27
4.8
3.4
5.0
5.2
kpa
—
8
59
5
38
1.33
0.23
1.6
1.7
—
—
—
0
0
14
116
1.23
0.23
6.1
4.9
215.9
247.5
u/l
0.63
14
109
5
42
1.20
0.21
9.0
3.5
8.4
32.5
u/ml
—
5
37
5
42
1.20
0.21
1.0
1.3
—
—
—
0
0
11
89
1.25
0.21
1.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
121
1238
0.88
0.19
5.7
5.2
1.9
1.8
mu/l
0.20
109
1138
11
91
1.23
0.18
5.3
3.0
47.2
69.7
ml/min/173m2
—
5
38
104
1070
0.91
0.17
5.2
4.3
14.5
14.6
pmol/l
0.11
94
978
19
214
0.87
0.17
1.6
1.9
—
—
—
0
0
8
70
1.15
0.16
1.1
1.4
—
—
—
0
0
123
1206
1.11
0.15
18.3
11.7
85.2
84.0
ml/min/173m2
0.24
109
970
9
105
0.85
0.13
1.3
1.5
—
—
—
0
0
21
191
1.12
0.12
1.9
1.7
—
—
—
0
0
120
1181
1.08
0.10
20.1
13.3
38.5
39.5
%
1.81
94
886
5
44
1.14
0.10
1.6
2.6
1.6
1.1
%
—
5
44
6
56
1.07
0.09
1.2
1.2
—
—
—
0
0
8
94
0.84
0.07
1.3
1.4
—
—
—
0
0
31
296
1.06
0.06
2.0
1.8
5.1
0.9
mg/l
0.80
23
230
18
190
0.94
0.04
1.5
1.8
—
—
—
0
0
94
947
0.98
0.01
3.5
3.6
—
—
—
0
0
13
126
1.03
0.00
1.2
1.6
—
—
—
0
0
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
6.9
—
0
5
0
8
0.00
0.00
0.0
1.3
—
0.3
—
0
8
0
5
0.00
0.00
0.0
1.0
—
27.8
—
0
5
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
4.8
—
—
—
0
0
5
52
0.96
0.00
1.8
3.8
48.0
38.8
%
—
5
52
0
5
0.00
0.00
0.0
12.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
69.1
—
0
7
0
7
0.00
0.00
0.0
1.0
—
95.0
—
0
7
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
6
66
0.91
0.00
1.8
1.4
449.2
323.7
mu/l
—
6
58
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_CERVIX_ADENO – Adenocarcinomas of cervix
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).